|Day Low/High||6.48 / 6.65|
|52 Wk Low/High||5.51 / 10.00|
We picked up more Abraxas Petroleum on weakness, while the market rebounded slightly after the FOMC announced the anticipated quarter-point rate hike.
We bulked up on Abraxas Petroleum and Yamana Gold on weakness, as the markets pulled back and investors positioned for next week’s FOMC meeting.
We booked some profits in Huntington Bancshares and Builders FirstSource, while markets digested the likelihood of a March rate hike.
LTE Calling Reduces Operator Costs, Increases Subscriber Satisfaction and Supports New Handover Features
Demonstration Based on Successful Interoperability Testing at First Ever ETSI Plugtest
We opened a new position in Abraxas Petroleum on its above-average growth potential, as stocks faced selling pressure this week.
Company Demonstrates Cloud DSC Management, Activation and Orchestration with Dorado Software's Redcell Product Suite
Sonus Future Proofs KT's Network with Support for SS7 and Diameter
Sonus SBC SWe Provides Telegate with a Secure, Cost Effective Solution for Unified SIP Interconnect Management
More than three-quarters of the companies in the S&P 500 have reported results, and 66% have exceeded expectations.
We view the stock's decline on mixed quarterly results as a buying opportunity.
In recent trading, shares of Sonus Networks, Inc. have crossed above the average analyst 12-month target price of $6.75, changing hands for $6.79/share.
We closed out our position in OraSure Technologies for an average gain of 105% gain.
We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.
We used a price decline to add to our position in TherapeuticsMD this week.
We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.
Sonus SBC 5400 Designed to Address Unique Real-Time Communications Challenges with Security, Interoperability and Scalability
We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.
We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.
We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.
We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.
We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.
In recent trading, shares of Sonus Networks, Inc. have crossed above the average analyst 12-month target price of $6.75, changing hands for $6.77/share.
We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.